Your browser doesn't support javascript.
loading
Nickel-Catalyzed Synthesis of Quinazolinediones.
Beutner, Gregory L; Hsiao, Yi; Razler, Thomas; Simmons, Eric M; Wertjes, William.
Affiliation
  • Beutner GL; Chemical and Synthetic Development, Bristol-Myers Squibb Company , One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States.
  • Hsiao Y; Chemical and Synthetic Development, Bristol-Myers Squibb Company , One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States.
  • Razler T; Chemical and Synthetic Development, Bristol-Myers Squibb Company , One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States.
  • Simmons EM; Chemical and Synthetic Development, Bristol-Myers Squibb Company , One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States.
  • Wertjes W; Chemical and Synthetic Development, Bristol-Myers Squibb Company , One Squibb Drive, New Brunswick, New Jersey 08903-0191, United States.
Org Lett ; 19(5): 1052-1055, 2017 03 03.
Article in En | MEDLINE | ID: mdl-28253632
ABSTRACT
A nickel(0)-catalyzed method for the synthesis of quinazolinediones from isatoic anhydrides and isocyanates is described. High-throughput ligand screening revealed that XANTPHOS was the optimal ligand for this transformation. Subsequent optimization studies, supported by kinetic analysis, significantly expanded the reaction scope. The reaction exhibits a case of substrate inhibition kinetics with respect to the isocyanate. Preliminary results on an asymmetric synthesis of atropisomeric quinazolinediones are reported.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Org Lett Journal subject: BIOQUIMICA Year: 2017 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Org Lett Journal subject: BIOQUIMICA Year: 2017 Document type: Article Affiliation country: United States